Literature DB >> 26881576

Oxaliplatin-induced posterior reversible encephalopathy syndrome with isolated involvement of pons.

Koay Hean Tang1.   

Abstract

Isolated pontine lesion can be caused by the posterior reversible encephalopathy syndrome (PRES). It does occur in the normotensive patient who is treated with oxaliplatin. We reported a case of 81-year-old Chinese man with metastatic colorectal carcinoma who was initially treated with capecitabine. No significant adverse effects were noted. However, the response to the treatment was poor. Subsequently, Xelox was given. He developed transient altered mental status. Oxaliplatin was thought to be the causative agent and was withheld. Magnetic resonance imaging brain revealed vasogenic edema in the pons that was reversible after 2 weeks, as well as complete resolution of clinical symptoms. Early identification of the reversible cause of isolated pontine lesion, such as chemo, triggered PRES is crucial to facilitate prompt treatment by removing the offending agent or reducing the dose.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26881576     DOI: 10.4103/0973-1482.146134

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  2 in total

1.  Oxaliplatin-induced posterior reversible encephalopathy syndrome (PRES).

Authors:  Taimoor Khalid Janjua; Muhammad Hassan; Hira Khan Afridi; Naila Anjum Zahid
Journal:  BMJ Case Rep       Date:  2017-10-04

Review 2.  Isolated pons involvement in Posterior Reversible Encephalopathy Syndrome: Case report and review of the literature.

Authors:  Mariangela Ferrara; Pietro Di Viesti; Vincenzo Inchingolo; Raffaela Rita Latino; Teresa Popolizio; Salvatore Angelo De Cosmo; Flavia Pugliese; Maurizio Angelo Leone
Journal:  eNeurologicalSci       Date:  2016-11-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.